Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahboubeh Yazdanifar

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|December 28, 2020
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer GrowthRu Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.
Archives of Medical Research|May 21, 2013
Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cellsMandana Mohyeddin Bonab, Maryam Mohajeri, Mohammad Ali Sahraian, et al.
Reviews in Medical Virology|December 16, 2021
Protective and pathological roles of regulatory immune cells in human cytomegalovirus infection following hematopoietic stem cell transplantationHaideh Namdari, Maryam Hosseini, Mahboubeh Yazdanifar, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 25, 2024
Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent HostRu Zhou, Shu-Ta Wu, Mahboubeh Yazdanifar, et al.
Biotechnology and Bioengineering|May 25, 2023
Reconstructing the cell-cell interaction network among mouse immune cellsSomayeh Azadian, Alireza Doustmohammadi, Mohadeseh Naseri, et al.
Frontiers in Immunology|September 7, 2021
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated ChallengesEhsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman, et al.
Frontiers in Cell and Developmental Biology|March 3, 2022
Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal AdenocarcinomaMukulika Bose, Priyanka Grover, Alexa J Sanders, et al.
Cells|September 14, 2019
Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal AdenocarcinomaMahboubeh Yazdanifar, Ru Zhou, Priyanka Grover, et al.
International Immunopharmacology|June 22, 2022
Controversial role of γδ T cells in pancreatic cancerFatemeh Nezhad Shamohammadi, Mahboubeh Yazdanifar, Mona Oraei, et al.
Stem Cell Research & Therapy|April 2, 2022
Hurdles to breakthrough in CAR T cell therapy of solid tumorsFaroogh Marofi, Harun Achmad, Dmitry Bokov, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|December 28, 2020
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer GrowthRu Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.
Archives of Medical Research|May 21, 2013
Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cellsMandana Mohyeddin Bonab, Maryam Mohajeri, Mohammad Ali Sahraian, et al.
Reviews in Medical Virology|December 16, 2021
Protective and pathological roles of regulatory immune cells in human cytomegalovirus infection following hematopoietic stem cell transplantationHaideh Namdari, Maryam Hosseini, Mahboubeh Yazdanifar, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 25, 2024
Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent HostRu Zhou, Shu-Ta Wu, Mahboubeh Yazdanifar, et al.
Biotechnology and Bioengineering|May 25, 2023
Reconstructing the cell-cell interaction network among mouse immune cellsSomayeh Azadian, Alireza Doustmohammadi, Mohadeseh Naseri, et al.
Frontiers in Immunology|September 7, 2021
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated ChallengesEhsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman, et al.
Frontiers in Cell and Developmental Biology|March 3, 2022
Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal AdenocarcinomaMukulika Bose, Priyanka Grover, Alexa J Sanders, et al.
Cells|September 14, 2019
Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal AdenocarcinomaMahboubeh Yazdanifar, Ru Zhou, Priyanka Grover, et al.
International Immunopharmacology|June 22, 2022
Controversial role of γδ T cells in pancreatic cancerFatemeh Nezhad Shamohammadi, Mahboubeh Yazdanifar, Mona Oraei, et al.
Stem Cell Research & Therapy|April 2, 2022
Hurdles to breakthrough in CAR T cell therapy of solid tumorsFaroogh Marofi, Harun Achmad, Dmitry Bokov, et al.
Pageof 3